View Exam | PowerPak

1. Which of the following is a guideline-recommended antiretroviral regimen for “most people with HIV”?

A. Elvitegravir (w/cobicistat)/tenofovir alafenamide/emtricitabine; EVG/c/TAF/FTC B. Bictegravir/tenofovir alafenamide/emtricitabine; BIC/TAF/FTC C. Darunavir (w/ritonavir or cobicistat) + (tenofovir alafenamide or tenofovir disoproxil fumarate) + (emtricitabine or lamivudine); (DRV/r or DRV/c) + (TAF or TDF) + (FTC or 3TC) D. Efavirenz + (tenofovir alafenamide or tenofovir disoproxil fumarate) + (emtricitabine or lamivudine); EFV + (TAF or TDF) + (FTC or 3TC)

2. Gastrointestinal upset is a common short-term adverse effect associated with which classes of antiretroviral medications for HIV?

A. Integrase strand transfer inhibitors (INSTIs) and nucleoside reverse transcriptase inhibitors (NRTIs) B. INSTIs and protease inhibitors (PIs) C. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) and PIs D. NRTIs and PIs

3. DC, a 35-year-old man having difficulty taking his antiretroviral therapy (ART) medications correctly due to food burden, consults with you about switching. He is currently on efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF). Since his regimen includes EFV, it should be taken on an empty stomach, preferably at bedtime. His work and social schedules are unpredictable, and he doesn't want to have to consider food at all in his ART. Which drug regimen would be more appropriate for DC?

A. Darunavir/cobicistat (DRV/c)/FTC/tenofovir alafenamide (TAF) B. Rilpivirine (RPV)/FTC/TDF C. Elvitegravir/cobicistat (EVG/c)/FTC/TAF D. Dolutegravir (DTG) + (TAF or TDF) + (FTC or lamivudine [3TC])

4. TJ is a 58-year-old woman with HIV and a family history of heart disease. She also has high blood pressure and is overweight. Her primary care provider says that she should avoid which medication due to her increased cardiovascular risk?

A. Darunavir/ritonavir (DRV/r) B. Rilpivirine (RPV) C. Elvitegravir/cobicistat (EVG/c) D. Atazanavir (ATV)

5. What is the most common comorbidity in people living with HIV (PLWH)?

A. Chronic ischemic heart disease B. Diabetes C. Hypertension D. Kidney disease

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is a guideline-recommended antiretroviral regimen for “most people with HIV”?

2. Gastrointestinal upset is a common short-term adverse effect associated with which classes of antiretroviral medications for HIV?

4. TJ is a 58-year-old woman with HIV and a family history of heart disease. She also has high blood pressure and is overweight. Her primary care provider says that she should avoid which medication due to her increased cardiovascular risk?

5. What is the most common comorbidity in people living with HIV (PLWH)?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is a guideline-recommended antiretroviral regimen for “most people with HIV”?

2. Gastrointestinal upset is a common short-term adverse effect associated with which classes of antiretroviral medications for HIV?

4. TJ is a 58-year-old woman with HIV and a family history of heart disease. She also has high blood pressure and is overweight. Her primary care provider says that she should avoid which medication due to her increased cardiovascular risk?

5. What is the most common comorbidity in people living with HIV (PLWH)?

« Return to Activity

Customers who Purchased
this Activity also Purchased